BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 23576806)

  • 1. Microarray determination of Bcl-2 family protein inhibition sensitivity in breast cancer cells.
    Hudson SG; Halleran DR; Nevaldine B; Shapiro A; Hutchison RE; Hahn PJ
    Exp Biol Med (Maywood); 2013 Feb; 238(2):248-56. PubMed ID: 23576806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic inhibition of breast cancer cell lines with a dual inhibitor of EGFR-HER-2/neu and a Bcl-2 inhibitor.
    Witters LM; Witkoski A; Planas-Silva MD; Berger M; Viallet J; Lipton A
    Oncol Rep; 2007 Feb; 17(2):465-9. PubMed ID: 17203189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
    Arisan ED; Kutuk O; Tezil T; Bodur C; Telci D; Basaga H
    Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs.
    Tanabe K; Kim R; Inoue H; Emi M; Uchida Y; Toge T
    Int J Oncol; 2003 Apr; 22(4):875-81. PubMed ID: 12632082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
    Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling.
    Koehler BC; Jassowicz A; Scherr AL; Lorenz S; Radhakrishnan P; Kautz N; Elssner C; Weiss J; Jaeger D; Schneider M; Schulze-Bergkamen H
    BMC Cancer; 2015 Nov; 15():919. PubMed ID: 26585594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of tamoxifen sensitivity by antisense Bcl-2 and trastuzumab in breast carcinoma cells.
    Kim R; Tanabe K; Emi M; Uchida Y; Toge T
    Cancer; 2005 May; 103(10):2199-207. PubMed ID: 15830342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents.
    Fan S; Wang JA; Yuan RQ; Rockwell S; Andres J; Zlatapolskiy A; Goldberg ID; Rosen EM
    Oncogene; 1998 Jul; 17(2):131-41. PubMed ID: 9674697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells.
    Pérez-Galán P; Roué G; López-Guerra M; Nguyen M; Villamor N; Montserrat E; Shore GC; Campo E; Colomer D
    Leukemia; 2008 Sep; 22(9):1712-20. PubMed ID: 18596739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
    Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
    Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VSV oncolysis in combination with the BCL-2 inhibitor obatoclax overcomes apoptosis resistance in chronic lymphocytic leukemia.
    Samuel S; Tumilasci VF; Oliere S; Nguyên TL; Shamy A; Bell J; Hiscott J
    Mol Ther; 2010 Dec; 18(12):2094-103. PubMed ID: 20842105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
    Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y
    Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12.
    Thomadaki H; Scorilas A
    Ann N Y Acad Sci; 2007 Jan; 1095():35-44. PubMed ID: 17404015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunomodulatory drug lenalidomide restores a vitamin D sensitive phenotype to the vitamin D resistant breast cancer cell line MDA-MB-231 through inhibition of BCL-2: potential for breast cancer therapeutics.
    Brosseau C; Colston K; Dalgleish AG; Galustian C
    Apoptosis; 2012 Feb; 17(2):164-73. PubMed ID: 22109882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Ca2+ in baicalein-induced apoptosis in human breast MDA-MB-231 cancer cells through mitochondria- and caspase-3-dependent pathway.
    Lee JH; Li YC; Ip SW; Hsu SC; Chang NW; Tang NY; Yu CS; Chou ST; Lin SS; Lino CC; Yang JS; Chung JG
    Anticancer Res; 2008; 28(3A):1701-11. PubMed ID: 18630529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
    Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP
    J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platinum resistant cancer cells conserve sensitivity to BH3 domains and obatoclax induced mitochondrial apoptosis.
    Crawford N; Chacko AD; Savage KI; McCoy F; Redmond K; Longley DB; Fennell DA
    Apoptosis; 2011 Mar; 16(3):311-20. PubMed ID: 21107700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis.
    Wittmann S; Bali P; Donapaty S; Nimmanapalli R; Guo F; Yamaguchi H; Huang M; Jove R; Wang HG; Bhalla K
    Cancer Res; 2003 Jan; 63(1):93-9. PubMed ID: 12517783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of bcl-2 and p21waf1 proteins in response of human breast cancer cell clones to Tomudex.
    Orlandi L; Bearzatto A; Abolafio G; De Marco C; Daidone MG; Zaffaroni N
    Br J Cancer; 1999 Sep; 81(2):252-60. PubMed ID: 10496350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acylpyrogallols as inhibitors of antiapoptotic Bcl-2 proteins.
    Tang G; Nikolovska-Coleska Z; Qiu S; Yang CY; Guo J; Wang S
    J Med Chem; 2008 Feb; 51(4):717-20. PubMed ID: 18237106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.